Stevanato unveils Deora pen injector for diabetes and weight management

Stevanato Group has introduced Deora, a multi-use, fixed-dose pen injector designed to support subcutaneous delivery of therapies for diabetes and weight management, as well as other drug development programmes. Deora simplifies dose administration with a pull-push mechanism: users pull to set the dose and push to inject. Deora accommodates fixed-dose volumes up to 0.75mL and is compatible with 1.5mL and 3mL cartridges. Credit: Stevanato Group / Business Wire. Stevanato Group has introduced Deora, a multi-use, fixed-dose pen injector designed to support subcutaneous delivery of therapies for diabetes and weight management, as well as other drug development programmes. The company stated…

Source: Medical Device Network